Sign in to view content

ASRS Updates in the Management of Diabetic Retinopathy DME and PDR in the Middle East and Africa

Sunir J. Garg, MD, FACS, FASRS

Video
Published 2023

Related

Time to Retinal Fluid Control With Faricimab vs Aflibercept in Patients With DME in the Phase 3 YOSEMITE/RHINE Trials
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2023
Six Monthly Intravitreal Aflibercept to Improve Macular Perfusion in Diabetic Retinopathy Without Macular Edema
Yoon Jeon Kim, MD
Annual Meeting Talks
2023
A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Updates from the Field
2021

Category: Diabetic Retinopathy

See more